From early experiments showing that TGFβ enhances the secretion of ECM proteins, we are now beginning to grasp how the cellular microenvironment in turn influences the actions of TGFβ; this is of particular relevance to coronary artery disease and intimal hyperplasia, during which extensive vascular remodelling occurs. Here, TGFB1 is linked to coronary artery disorder.